SPORTIELLO, Liberata
 Distribuzione geografica
Continente #
EU - Europa 5.220
NA - Nord America 2.299
AS - Asia 2.236
SA - Sud America 369
AF - Africa 37
OC - Oceania 3
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.166
Nazione #
RU - Federazione Russa 3.637
US - Stati Uniti d'America 2.258
SG - Singapore 722
CN - Cina 538
IE - Irlanda 466
IT - Italia 385
VN - Vietnam 347
BR - Brasile 304
HK - Hong Kong 242
GB - Regno Unito 184
DE - Germania 156
UA - Ucraina 131
KR - Corea 98
JP - Giappone 83
IN - India 78
GR - Grecia 47
FI - Finlandia 46
TR - Turchia 38
AR - Argentina 32
FR - Francia 32
SE - Svezia 26
NL - Olanda 21
CA - Canada 20
ID - Indonesia 18
ZA - Sudafrica 17
AT - Austria 15
EC - Ecuador 15
BD - Bangladesh 13
BE - Belgio 13
CZ - Repubblica Ceca 12
IQ - Iraq 12
MX - Messico 11
ES - Italia 9
PL - Polonia 9
IR - Iran 8
MA - Marocco 7
PK - Pakistan 7
IL - Israele 6
CH - Svizzera 5
CL - Cile 5
DK - Danimarca 5
PY - Paraguay 5
EG - Egitto 4
CO - Colombia 3
HR - Croazia 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
NP - Nepal 3
PE - Perù 3
RS - Serbia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
PH - Filippine 2
TN - Tunisia 2
VE - Venezuela 2
AQ - Antartide 1
AU - Australia 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 10.166
Città #
Moscow 1.326
Dublin 463
San Jose 430
Singapore 354
Santa Clara 279
Hong Kong 240
Jacksonville 206
Chandler 176
Ashburn 125
Ho Chi Minh City 98
Seoul 96
Beijing 93
Hefei 78
Ann Arbor 68
Dong Ket 66
Hanoi 63
Princeton 54
Aversa 50
Roxbury 48
Medford 46
Bremen 45
Bengaluru 34
Woodbridge 34
The Dalles 32
Orem 31
Naples 29
Caserta 28
Wilmington 28
São Paulo 27
Düsseldorf 26
Dallas 24
Milan 21
Mountain View 21
Nanjing 21
New York 21
Da Nang 19
Los Angeles 19
Des Moines 17
Genoa 17
Munich 16
Boardman 15
Dearborn 15
Amsterdam 14
Rome 14
Brussels 13
Cambridge 13
Chennai 13
Nuremberg 13
Kunming 12
London 12
Jinan 11
Falkenstein 10
Haiphong 10
Helsinki 10
Johannesburg 10
Manchester 10
Napoli 10
Biên Hòa 9
Jakarta 9
Phủ Lý 9
Auburn Hills 8
Hanover 8
Messina 8
Pomigliano d'Arco 8
Salerno 8
Brasília 7
Brno 7
Curitiba 7
Guangzhou 7
Mexico City 7
Mumbai 7
Rio de Janeiro 7
San Mateo 7
Shenyang 7
Stockholm 7
Toronto 7
Vienna 7
Atlanta 6
Changsha 6
Chengdu 6
Frankfurt am Main 6
Guarulhos 6
Hillsboro 6
Hải Dương 6
Norwalk 6
San Francisco 6
Warsaw 6
Asunción 5
Belo Horizonte 5
Cagliari 5
Can Tho 5
Columbus 5
Hebei 5
Nanchang 5
Piracicaba 5
Redwood City 5
Tel Aviv 5
Venice 5
Avellino 4
Basra 4
Totale 5.348
Nome #
Adverse drug reactions and gender differences: What changes in drug safety? 220
Bisphosphonate-related osteonecrosis of the jaw: an italian post-marketing surveillance analysis 192
Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy 187
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 185
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 180
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 177
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 173
Complete resistance after maximal dose of rocuronium 165
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study. 163
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 162
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 158
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials 157
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 156
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: An observational study in real-life settings 156
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 153
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 152
Pattern of statin use in southern Italian primary care: Can prescription databases be used for monitoring long-term adherence to the treatment? 151
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 150
Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve 150
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 148
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 144
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 139
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 139
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 138
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system 137
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 137
Current pharmacological treatments for COVID-19: What's next? 137
Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction’s Reporting? A Pharmacovigilance Study in Southern Italy 136
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 135
Persistence in therapy with risperidone and aripiprazole in pediatric outpatients: A 2-year naturalistic comparison 134
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management 133
Disclosing negative trial results – procedure 132
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 129
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 129
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 129
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database 128
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 127
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 127
Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study. 126
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 126
Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch 125
Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand? 122
Hospital consumption of antibiotics at the Policlinico Hospital of the Second University of Naples: results of retrospective data collection 122
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study 118
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review 116
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination 115
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database 115
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data 113
DPP-4 inhibitors: Pharmacological differences and their clinical implications 113
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 112
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 111
Rational use of antibiotics for the management of children's respiratory tract infections in the ambulatory setting: An evidence-based consensus by the Italian Society of Preventive and Social Pediatrics 110
Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case–control study in Italy 107
Neutral endopeptidase (neprilysin) 106
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin. 106
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 106
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 105
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 105
Therapeutic strategies to fight COVID-19: Which is the status artis? 105
Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021) 104
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 104
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 103
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 102
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 100
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 100
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 100
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series 99
Notification of undesirable effects of cosmetics and toiletries 98
Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF) 98
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 98
Should we abandon statins in the prevention of bone fractures? 97
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 97
MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study 97
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 94
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 93
Immune checkpoint inhibitors and metabolic events: results from a European safety analysis. 85
Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies. 84
The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice 79
It is the time to change the paradigms of pregnant and breastfeeding women in clinical research! 76
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 75
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 71
Sex and gender differences and pharmacovigilance: a knot still to be untied 64
Oropharyngeal adverse drug reactions: knowledge, attitudes, and practice (KAP) among Italian healthcare professionals and students 63
Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines 8
Totale 10.318
Categoria #
all - tutte 31.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 0 0 0 0 22 57 71
2021/2022338 9 8 2 3 123 10 12 9 15 16 22 109
2022/2023872 91 21 12 58 95 58 6 48 423 6 35 19
2023/2024424 26 10 30 23 122 27 12 48 21 16 29 60
2024/20251.307 10 31 28 41 180 193 194 117 195 100 114 104
2025/20266.128 254 320 311 299 510 3.368 245 495 201 125 0 0
Totale 10.318